Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) was the target of a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 170,400 shares, a drop of 56.9% from the August 15th total of 395,600 shares. Approximately 14.2% of the shares of the stock are short sold. Based on an average trading volume of 1,020,000 shares, the days-to-cover ratio is currently 0.2 days.

Ainos Stock Performance

Shares of NASDAQ:AIMD opened at $0.52 on Friday. The stock’s 50 day moving average price is $0.66 and its 200 day moving average price is $0.92. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.48 and a quick ratio of 1.45. Ainos has a 12 month low of $0.48 and a 12 month high of $4.32.

Ainos (NASDAQ:AIMD) last released its earnings results on Monday, August 5th. The company reported ($0.49) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 64.54% and a negative net margin of 15,348.14%.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.